127 related articles for article (PubMed ID: 9157995)
1. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
3. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive allelotyping of human hepatocellular carcinoma.
Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
Piao Z; Park C; Kim JJ; Kim H
Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
[TBL] [Abstract][Full Text] [Related]
8. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.
Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y
Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616
[TBL] [Abstract][Full Text] [Related]
10. Allelotype study of primary hepatocellular carcinoma.
Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
[TBL] [Abstract][Full Text] [Related]
12. [Loss of heterozygosity in hepatocellular carcinoma].
Takahashi K; Kudo J; Ishibashi H; Niho Y
Nihon Rinsho; 1993 Feb; 51(2):370-4. PubMed ID: 8096550
[TBL] [Abstract][Full Text] [Related]
13. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
14. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma.
Pineau P; Nagai H; Prigent S; Wei Y; Gyapay G; Weissenbach J; Tiollais P; Buendia MA; Dejean A
Oncogene; 1999 May; 18(20):3127-34. PubMed ID: 10340384
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
[TBL] [Abstract][Full Text] [Related]
16. Loss of somatic heterozygosity in hepatocellular carcinoma.
Walker GJ; Hayward NK; Falvey S; Cooksley WG
Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
20. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
